Division of Imaging and Oncology, University Medical Centre Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.
Department of Surgery, St. Antonius Hospital, Utrecht, The Netherlands.
Breast Cancer Res Treat. 2022 Feb;191(3):553-564. doi: 10.1007/s10549-021-06458-3. Epub 2021 Dec 1.
To evaluate perceived access to health care and preferences for health care provision among patients (being) treated for breast cancer during the COVID-19 pandemic.
Longitudinal study within the prospective, multicenter UMBRELLA cohort of patients (being) treated for breast cancer. All cohort participants enrolled in UMBRELLA between October 2013 and November 2020 were sent a COVID-19-specific survey during the first and second wave of the COVID-19 pandemic, i.e., April 2020 and November 2020, respectively.
In total, 1106 (69.3%) and 822 (50.9%) cohort participants completed the survey in the first and second wave, respectively. The proportion of patients experiencing that their treatment or follow-up care was affected due to COVID-19 decreased from 28.4% (n = 198) in April 2020 to 14.8% (n = 103) in November 2020. Throughout the pandemic, one or more hospital consultations were postponed in 10.0% (n = 82) of all patients and changed into a teleconsultation in 23.1% (n = 190). The proportion of patients who experienced a higher threshold to contact their general practitioner due to COVID-19 decreased from 29.9% (n = 204) in the first wave to 20.8% (n = 145) in the second wave. In-person consultations remained most preferred in 35.2% (n = 289) of all patients. Nearly half of all patients (48.3%, n = 396) indicated that telehealth would be a useful alternative for in-person consultations in future.
Perceived access to health care has improved substantially throughout the pandemic. Digital care is well received by patients (being) treated for breast cancer.
评估在 COVID-19 大流行期间接受乳腺癌治疗的患者对医疗保健的可及性和医疗服务提供偏好。
在接受乳腺癌治疗的前瞻性、多中心 UMBRELLA 队列的纵向研究中。2013 年 10 月至 2020 年 11 月期间,UMBRELLA 招募的所有队列参与者在 COVID-19 大流行的第一波和第二波期间,分别于 2020 年 4 月和 2020 年 11 月收到了一份 COVID-19 专项调查。
共有 1106 名(69.3%)和 822 名(50.9%)队列参与者分别在第一波和第二波完成了调查。由于 COVID-19,治疗或随访受到影响的患者比例从 2020 年 4 月的 28.4%(n=198)降至 2020 年 11 月的 14.8%(n=103)。在整个大流行期间,10.0%(n=82)的所有患者都推迟了一次或多次医院就诊,其中 23.1%(n=190)改为远程咨询。由于 COVID-19,更多患者认为与他们的全科医生联系的门槛提高了,从第一波的 29.9%(n=204)降至第二波的 20.8%(n=145)。面对面咨询在所有患者中仍然是最受欢迎的,占 35.2%(n=289)。几乎一半的患者(48.3%,n=396)表示,在未来,远程医疗将是面对面咨询的一个有用替代方式。
在整个大流行期间,患者对医疗保健的可及性有了显著提高。数字医疗受到接受乳腺癌治疗的患者的欢迎。